Kent L. Nastiuk - Publications

Affiliations: 
Cancer Genetics Roswell Park Cancer Institute, Buffalo, NY, United States 
 Pathology University of California, Irvine, Irvine, CA 
Area:
apoptosis

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pan C, Jaiswal Agrawal N, Zulia Y, Singh S, Sha K, Mohler JL, Eng KH, Chakkalakal J, Krolewski JJ, Nastiuk KL. Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia. Jci Insight. PMID 32078585 DOI: 10.1172/Jci.Insight.127018  0.334
2019 Lerman I, Ma X, Seger C, Maolake A, Garcia-Hernandez ML, Rangel-Moreno J, Ackerman J, Nastiuk KL, Susiarjo M, Hammes SR. Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression. Molecular Cancer Research : McR. PMID 30610107 DOI: 10.1158/1541-7786.Mcr-18-0638  0.405
2019 Krolewski JJ, Sha K, Mastri M, Tang D, Eng K, Nastiuk KL. Abstract A084: Towards combining androgen deprivation and immunotherapy to prevent progression to castration-resistant prostate cancer Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A084  0.375
2019 Krolewski JJ, Sha K, Nastiuk KL. Abstract 4486: Androgen-deprivation therapy promotes immune suppression in a murine model of prostate cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-4486  0.346
2019 Schmitthenner HF, Dobson DE, Jones KG, Akporji N, Soika DQM, Nastiuk KL, Hornak JP. Frontispiece: Modular Synthesis of DOTA‐Metal‐Based PSMA‐Targeted Imaging Agents for MRI and PET of Prostate Cancer Chemistry – a European Journal. 25. DOI: 10.1002/Chem.201986162  0.312
2018 Maolake A, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Makino T, Naito R, Shigehara K, Kadono Y, Hiratsuka K, Wufuer G, Nastiuk KL, Mizokami A. Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis via CCR7 upregulation. Cancer Science. PMID 29575464 DOI: 10.1111/Cas.13586  0.377
2017 Lerman I, Garcia-Hernandez ML, Rangel-Moreno J, Chiriboga L, Pan C, Nastiuk KL, Krolewski JJ, Sen A, Hammes SR. Infiltrating Myeloid Cells Exert Pro-Tumorigenic Actions via Neutrophil Elastase. Molecular Cancer Research : McR. PMID 28512253 DOI: 10.1158/1541-7786.Mcr-17-0003  0.392
2016 Pan C, Singh S, Sahasrabudhe DM, Chakkalakal JV, Krolewski JJ, Nastiuk KL. TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice. Endocrinology. en20161580. PMID 27611336 DOI: 10.1210/En.2016-1580  0.34
2016 Dogra V, Chinni B, Singh S, Schmitthenner H, Rao N, Krolewski JJ, Nastiuk KL. Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates. Journal of Biomedical Optics. 21: 66019. PMID 27367255 DOI: 10.1117/1.Jbo.21.6.066019  0.368
2015 Sha K, Yeh S, Chang C, Nastiuk KL, Krolewski JJ. TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures. Oncotarget. 6: 25726-40. PMID 26327448 DOI: 10.18632/Oncotarget.4535  0.319
2015 Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals. Oncotarget. 6: 12326-39. PMID 25940439 DOI: 10.18632/Oncotarget.3619  0.355
2015 Xiao GQ, Unger P, Yang Q, Kinoshita Y, Singh K, McMahon L, Nastiuk K, Sha K, Krolewski J, Burstein D. Loss of PLZF expression in prostate cancer by immunohistochemistry correlates with tumor aggressiveness and metastasis. Plos One. 10: e0121318. PMID 25807461 DOI: 10.1371/Journal.Pone.0121318  0.355
2012 Davis JS, Nastiuk KL. Abstract C10: Tumor necrosis factor is necessary but not sufficient for castration-induced prostate regression Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-C10  0.401
2011 Davis JS, Nastiuk KL, Krolewski JJ. TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable. Molecular Endocrinology (Baltimore, Md.). 25: 611-20. PMID 21292828 DOI: 10.1210/Jcem.96.3.Zeg873A  0.396
2009 Yoo KS, Nastiuk KL, Krolewski JJ. Transforming growth factor beta1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells. International Journal of Cancer. Journal International Du Cancer. 124: 834-42. PMID 19048627 DOI: 10.1002/Ijc.24024  0.376
2008 Nastiuk KL, Krolewski JJ. FLIP-ping out: death receptor signaling in the prostate. Cancer Biology & Therapy. 7: 1171-9. PMID 18719361 DOI: 10.4161/Cbt.7.8.6712  0.414
2008 El Fiky A, Pioli P, Azam A, Yoo K, Nastiuk KL, Krolewski JJ. Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9. Cellular Signalling. 20: 1400-8. PMID 18456457 DOI: 10.1016/J.Cellsig.2008.03.006  0.323
2008 Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ. FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene. 27: 4422-33. PMID 18391984 DOI: 10.1038/Onc.2008.80  0.429
2008 Nastiuk KL, Yoo K, Lo K, Su K, Yeung P, Kutaka J, Danielpour D, Krolewski JJ. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells. Molecular Cancer Research : McR. 6: 231-42. PMID 18314484 DOI: 10.1158/1541-7786.Mcr-07-0386  0.381
2007 Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ. In vivo MRI volumetric measurement of prostate regression and growth in mice. Bmc Urology. 7: 12. PMID 17650332 DOI: 10.1186/1471-2490-7-12  0.363
2003 Nastiuk KL, Kim JW, Mann M, Krolewski JJ. Androgen regulation of FLICE-like inhibitory protein gene expression in the rat prostate. Journal of Cellular Physiology. 196: 386-93. PMID 12811833 DOI: 10.1002/Jcp.10283  0.441
1999 Nastiuk KL, Mansukhani M, Terry MB, Kularatne P, Rubin MA, Melamed J, Gammon MD, Ittmann M, Krolewski JJ. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. The Prostate. 40: 172-7. PMID 10398279 DOI: 10.1002/(Sici)1097-0045(19990801)40:3<172::Aid-Pros5>3.0.Co;2-R  0.32
1997 Marin P, Nastiuk KL, Daniel N, Girault JA, Czernik AJ, Glowinski J, Nairn AC, Prémont J. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 3445-54. PMID 9133370 DOI: 10.1523/Jneurosci.17-10-03445.1997  0.437
1996 Picciotto MR, Nastiuk KL, Nairn AC. Structure, regulation, and function of calcium/calmodulin-dependent protein kinase I. Advances in Pharmacology (San Diego, Calif.). 36: 251-75. PMID 8783563 DOI: 10.1016/S1054-3589(08)60585-2  0.434
1995 Nastiuk KL, Clayton DF. The canary androgen receptor mRNA is localized in the song control nuclei of the brain and is rapidly regulated by testosterone. Journal of Neurobiology. 26: 213-24. PMID 7707043 DOI: 10.1002/Neu.480260206  0.564
1994 Nastiuk KL, Clayton DF. Seasonal and tissue-specific regulation of canary androgen receptor messenger ribonucleic acid. Endocrinology. 134: 640-9. PMID 8299561 DOI: 10.1210/Endo.134.2.8299561  0.559
1994 Nastiuk KL, Mello CV, George JM, Clayton DF. Immediate-early gene responses in the avian song control system: cloning and expression analysis of the canary c-jun cDNA. Brain Research. Molecular Brain Research. 27: 299-309. PMID 7898314 DOI: 10.1016/0169-328X(94)90013-2  0.611
1992 Nagel G, Hwang TC, Nastiuk KL, Nairn AC, Gadsby DC. The protein kinase A-regulated cardiac Cl- channel resembles the cystic fibrosis transmembrane conductance regulator. Nature. 360: 81-4. PMID 1279437 DOI: 10.1038/360081A0  0.415
1988 Clayton DF, Huecas ME, Sinclair-Thompson EY, Nastiuk KL, Nottebohm F. Probes for rare mRNAs reveal distributed cell subsets in canary brain. Neuron. 1: 249-61. PMID 3272171 DOI: 10.1016/0896-6273(88)90146-8  0.579
Show low-probability matches.